Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Bondronat

Bondronat 2 mg concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 7–8

HOS-085644 · Präparat HOS-083171

7 System Organ Common Uncommon Rare Very rare Not known Class Gastrointestinal Diarrhoea, Gastroenteritis, disorders vomiting, gastritis, mouth dyspepsia, ulceration, gastrointestinal dysphagia, cheilitis pain, tooth disorder Hepatobiliary Cholelithiasis disorders Skin and Skin disorder, Rash, alopecia Stevens- subcutaneous ecchymosis Johnson tissue disorders Syndrome†, Erythema Multiforme†, Dermatitis Bullous† Musculoskeletal Osteoarthritis, Atypical Osteonecrosis Atypical and connective myalgia, subtrochanteric of jaw†** fractures of tissue disorders arthralgia, joint and diaphyseal Osteonecrosis long bones disorder, femoral of the external other than the bone pain fractures† auditory canal femur (bisphosphonat e class adverse reaction)† Renal and Urinary retention, urinary renal cyst disorders Reproductive Pelvic pain system and breast disorders General Pyrexia, Hypothermia disorders and influenza-like administration illness**, oedema site conditions peripheral, asthenia, thirst Investigations Gamma-GT Blood alkaline increased, phosphatase creatinine increase, weight increased decrease Injury, Injury, injection site poisoning and pain procedural complications **See further information below †Identified in post-marketing experience.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.